Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

988
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
988
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

861
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
861

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beaded opacities in a myopic eye after vitreoretinal surgery forming a nice Valentine.

Journal francais d'ophtalmologie·2026
Same author

Barriers and Facilitators for Accessing Oral Health Care for Ukrainian Newcomers to Nova Scotia.

JDR clinical and translational research·2025
Same author

Systemic lupus erythematosus presenting as bilateral acute myopic shift imaged by SS-OCT.

Journal francais d'ophtalmologie·2025
Same author

Changes in rates of endophthalmitis after cataract surgery over the last 23years.

Journal francais d'ophtalmologie·2024
Same author

[Bacterial keratitis: Retrospective and prospective 2024].

Journal francais d'ophtalmologie·2024
Same author

Sex estimation in the South-East Asian population: A systematic review.

The Malaysian journal of pathology·2024

Related Experiment Video

Updated: Dec 7, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.3K

Corneal crosslinking in keratoconus management.

S Saad1, R Saad1, L Jouve1

  • 1CHNO des Quinze-Vingts, IHU ForeSight, INSERM-DGOS CIC 1423, 28, rue de Charenton, 75012 Paris, France.

Journal Francais D'Ophtalmologie
|September 25, 2020
PubMed
Summary

Corneal crosslinking (CXL) stiffens the cornea to halt progressive ectatic diseases. This review covers CXL principles, techniques, evidence, and future directions for this established therapeutic option.

Keywords:
CorneaCornéeCrosslinkingKeratoconusKératocône

More Related Videos

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.2K
Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

8.1K

Related Experiment Videos

Last Updated: Dec 7, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.3K
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.2K
Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

8.1K

Area of Science:

  • Ophthalmology
  • Biomedical Engineering

Background:

  • Corneal crosslinking (CXL) has been a primary treatment for keratoconus for 20 years.
  • CXL utilizes ultraviolet-A light and riboflavin to increase corneal rigidity.
  • Its application extends from ectatic diseases to corneal infections, though controversies persist.

Purpose of the Study:

  • To provide an updated review of corneal crosslinking (CXL).
  • To detail the fundamental principles and current techniques of CXL.
  • To explore emerging perspectives and future developments in CXL procedures.

Main Methods:

  • Review of existing literature on corneal crosslinking (CXL).
  • Analysis of basic science and clinical evidence for various CXL techniques.
  • Examination of current controversies and future research directions.

Main Results:

  • Corneal crosslinking (CXL) is a well-established procedure for managing ectatic corneal diseases.
  • Multiple CXL techniques exist, supported by varying levels of clinical evidence.
  • Ongoing debates surround CXL's precise role and optimal application.

Conclusions:

  • Corneal crosslinking (CXL) remains a key treatment for halting corneal ectasia progression.
  • Further research and standardization are needed to address existing controversies.
  • Future developments may expand CXL's therapeutic indications and efficacy.